News & Topics
Persistence of COVID-19 vaccine efficacy in patients with immune diseases (Kumanogoh G, in Lancet Reg Health West Pac.)
Patients with autoimmune diseases are at high risk of COVID-19、but the medium-term effects of immunosuppression on vaccine efficacy are unknown.
Yasuhiro Kato, Atsushi Kumanogoh (Graduate School of Medicine, Osaka University/Immunopathology, IFReC), and the research group analyzed immune dynamics after vaccination against COVID-19 in patients with autoimmune diseases. They revealed some immunosuppressive therapies attenuate neutralizing antibodies against the virus.
Article (External Link)
Immunology Frontier Research Center, Osaka University (WPI-IFReC)